CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.300
+0.010 (0.44%)
Oct 9, 2025, 11:07 AM EDT - Market open
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $29.25 million as of October 9, 2025. Its market cap has decreased by -47.39% in one year.
Market Cap
29.25M
Enterprise Value
20.71M
1-Year Change
-47.39%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since May 14, 2015, CollPlant Biotechnologies's market cap has decreased from $29.72M to $29.25M, a decrease of -1.58%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 27.98M | -32.16% |
| Dec 31, 2024 | 41.24M | -43.65% |
| Dec 29, 2023 | 73.18M | -21.52% |
| Dec 30, 2022 | 93.25M | -46.69% |
| Dec 31, 2021 | 174.91M | 147.09% |
| Dec 31, 2020 | 70.79M | 129.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.24B |
| Johnson & Johnson | 452.08B |
| AbbVie | 411.34B |
| UnitedHealth Group | 328.79B |
| AstraZeneca | 265.89B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.88B |